Jounce Therapeutics, Inc.

Delisted

CIK 1640455fmd_0QEQDS7A1NTPNM9CM2DZGHGF7SManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2015 to Dec 31, 2022, 29 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).